Metastatic renal carcinoma: Evaluation of antiangiogenic therapy with dynamic ... - UroToday PDF Print
UroTodayIn two phase-III trials involving 51 patients with metastatic renal cell carcinoma (38 men, 13 women; age range, 30-80 years) receiving antiangiogenic drugs

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.